- call +1-201-465-4211
- email sales@mrinsights.biz
Hereditary cancer testing is a process of identifying an inherited gene mutation that increases the risk of cancer development. It mainly includes predictive genetic testing and clinical DNA sequencing, in predictive genetic testing, patient’s family history is analyzed for any inherited mutation from ancestry. In DNA sequencing, entire DNA or genome of an individual is analyzed. It is useful for testing many genetic mutations at a time.
Scope of the Report:
This report studies the Hereditary Cancer Testing market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Hereditary Cancer Testing market by product type and applications/end industries.
The global Hereditary Cancer Testing market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Hereditary Cancer Testing.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Myriad Genetics
Myogenes
Laboratory Corporation of America
Biocartis
Quest Diagnostics
Pathway Genomics
Invitae Corporation
Strand Life Sciences
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Biopsy
Imaging
Others
Market Segment by Applications, can be divided into
Hospital
Clinics
Diagnostic Centers
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Hereditary Cancer Testing Market Overview
1.1 Product Overview and Scope of Hereditary Cancer Testing
1.2 Classification of Hereditary Cancer Testing by Types
1.2.1 Global Hereditary Cancer Testing Revenue Comparison by Types (2017-2023)
1.2.2 Global Hereditary Cancer Testing Revenue Market Share by Types in 2017
1.2.3 Biopsy
1.2.4 Imaging
1.2.5 Others
1.3 Global Hereditary Cancer Testing Market by Application
1.3.1 Global Hereditary Cancer Testing Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Diagnostic Centers
1.4 Global Hereditary Cancer Testing Market by Regions
1.4.1 Global Hereditary Cancer Testing Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Hereditary Cancer Testing Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Hereditary Cancer Testing Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Hereditary Cancer Testing Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Hereditary Cancer Testing Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Hereditary Cancer Testing Status and Prospect (2013-2023)
1.5 Global Market Size of Hereditary Cancer Testing (2013-2023)
2 Manufacturers Profiles
2.1 Myriad Genetics
2.1.1 Business Overview
2.1.2 Hereditary Cancer Testing Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Myriad Genetics Hereditary Cancer Testing Revenue, Gross Margin and Market Share (2016-2017)
2.2 Myogenes
2.2.1 Business Overview
2.2.2 Hereditary Cancer Testing Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Myogenes Hereditary Cancer Testing Revenue, Gross Margin and Market Share (2016-2017)
2.3 Laboratory Corporation of America
2.3.1 Business Overview
2.3.2 Hereditary Cancer Testing Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Laboratory Corporation of America Hereditary Cancer Testing Revenue, Gross Margin and Market Share (2016-2017)
2.4 Biocartis
2.4.1 Business Overview
2.4.2 Hereditary Cancer Testing Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Biocartis Hereditary Cancer Testing Revenue, Gross Margin and Market Share (2016-2017)
2.5 Quest Diagnostics
2.5.1 Business Overview
2.5.2 Hereditary Cancer Testing Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Quest Diagnostics Hereditary Cancer Testing Revenue, Gross Margin and Market Share (2016-2017)
2.6 Pathway Genomics
2.6.1 Business Overview
2.6.2 Hereditary Cancer Testing Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Pathway Genomics Hereditary Cancer Testing Revenue, Gross Margin and Market Share (2016-2017)
2.7 Invitae Corporation
2.7.1 Business Overview
2.7.2 Hereditary Cancer Testing Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Invitae Corporation Hereditary Cancer Testing Revenue, Gross Margin and Market Share (2016-2017)
2.8 Strand Life Sciences
2.8.1 Business Overview
2.8.2 Hereditary Cancer Testing Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Strand Life Sciences Hereditary Cancer Testing Revenue, Gross Margin and Market Share (2016-2017)
3 Global Hereditary Cancer Testing Market Competition, by Players
3.1 Global Hereditary Cancer Testing Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Hereditary Cancer Testing Players Market Share
3.2.2 Top 10 Hereditary Cancer Testing Players Market Share
3.3 Market Competition Trend
4 Global Hereditary Cancer Testing Market Size by Regions
4.1 Global Hereditary Cancer Testing Revenue and Market Share by Regions
4.2 North America Hereditary Cancer Testing Revenue and Growth Rate (2013-2018)
4.3 Europe Hereditary Cancer Testing Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Hereditary Cancer Testing Revenue and Growth Rate (2013-2018)
4.5 South America Hereditary Cancer Testing Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Hereditary Cancer Testing Revenue and Growth Rate (2013-2018)
5 North America Hereditary Cancer Testing Revenue by Countries
5.1 North America Hereditary Cancer Testing Revenue by Countries (2013-2018)
5.2 USA Hereditary Cancer Testing Revenue and Growth Rate (2013-2018)
5.3 Canada Hereditary Cancer Testing Revenue and Growth Rate (2013-2018)
5.4 Mexico Hereditary Cancer Testing Revenue and Growth Rate (2013-2018)
6 Europe Hereditary Cancer Testing Revenue by Countries
6.1 Europe Hereditary Cancer Testing Revenue by Countries (2013-2018)
6.2 Germany Hereditary Cancer Testing Revenue and Growth Rate (2013-2018)
6.3 UK Hereditary Cancer Testing Revenue and Growth Rate (2013-2018)
6.4 France Hereditary Cancer Testing Revenue and Growth Rate (2013-2018)
6.5 Russia Hereditary Cancer Testing Revenue and Growth Rate (2013-2018)
6.6 Italy Hereditary Cancer Testing Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Hereditary Cancer Testing Revenue by Countries
7.1 Asia-Pacific Hereditary Cancer Testing Revenue by Countries (2013-2018)
7.2 China Hereditary Cancer Testing Revenue and Growth Rate (2013-2018)
7.3 Japan Hereditary Cancer Testing Revenue and Growth Rate (2013-2018)
7.4 Korea Hereditary Cancer Testing Revenue and Growth Rate (2013-2018)
7.5 India Hereditary Cancer Testing Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Hereditary Cancer Testing Revenue and Growth Rate (2013-2018)
8 South America Hereditary Cancer Testing Revenue by Countries
8.1 South America Hereditary Cancer Testing Revenue by Countries (2013-2018)
8.2 Brazil Hereditary Cancer Testing Revenue and Growth Rate (2013-2018)
8.3 Argentina Hereditary Cancer Testing Revenue and Growth Rate (2013-2018)
8.4 Colombia Hereditary Cancer Testing Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Hereditary Cancer Testing by Countries
9.1 Middle East and Africa Hereditary Cancer Testing Revenue by Countries (2013-2018)
9.2 Saudi Arabia Hereditary Cancer Testing Revenue and Growth Rate (2013-2018)
9.3 UAE Hereditary Cancer Testing Revenue and Growth Rate (2013-2018)
9.4 Egypt Hereditary Cancer Testing Revenue and Growth Rate (2013-2018)
9.5 Nigeria Hereditary Cancer Testing Revenue and Growth Rate (2013-2018)
9.6 South Africa Hereditary Cancer Testing Revenue and Growth Rate (2013-2018)
10 Global Hereditary Cancer Testing Market Segment by Type
10.1 Global Hereditary Cancer Testing Revenue and Market Share by Type (2013-2018)
10.2 Global Hereditary Cancer Testing Market Forecast by Type (2018-2023)
10.3 Biopsy Revenue Growth Rate (2013-2023)
10.4 Imaging Revenue Growth Rate (2013-2023)
10.5 Others Revenue Growth Rate (2013-2023)
11 Global Hereditary Cancer Testing Market Segment by Application
11.1 Global Hereditary Cancer Testing Revenue Market Share by Application (2013-2018)
11.2 Hereditary Cancer Testing Market Forecast by Application (2018-2023)
11.3 Hospital Revenue Growth (2013-2018)
11.4 Clinics Revenue Growth (2013-2018)
11.5 Diagnostic Centers Revenue Growth (2013-2018)
12 Global Hereditary Cancer Testing Market Size Forecast (2018-2023)
12.1 Global Hereditary Cancer Testing Market Size Forecast (2018-2023)
12.2 Global Hereditary Cancer Testing Market Forecast by Regions (2018-2023)
12.3 North America Hereditary Cancer Testing Revenue Market Forecast (2018-2023)
12.4 Europe Hereditary Cancer Testing Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Hereditary Cancer Testing Revenue Market Forecast (2018-2023)
12.6 South America Hereditary Cancer Testing Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Hereditary Cancer Testing Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Hereditary Cancer Testing Picture
Table Product Specifications of Hereditary Cancer Testing
Table Global Hereditary Cancer Testing and Revenue (Million USD) Market S
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
